Strategic Collaboration to Address Critical Healthcare Needs and Expand Access to Life-Changing Treatments ...

A staggering 800% increase in licensing agreement deal values for messenger ribonucleic acid (mRNA)-based innovator ...

Domestic pharmaceutical companies say losing patent rights flexibilities will make medicines more expensive, as producing ...

Eli Lilly (NYSE: LLY) plans to invest $206M to expand its Suzhou, China site for Type 2 diabetes and obesity drugs. The ...

RNA-based vaccines, which instruct cells to produce proteins that can prevent or treat disease, show great promise in ...

Large pharmaceutical companies were out in force at this week’s 2024 Cell & Gene Meeting on the Mesa, as they look to expand ...

Report Ocean, a leading strategic consulting and market research firm, in its recent study, estimated the Global Pharmaceutical Excipients Market size at USD 8.89 billion in 2023. During the forecast ...

and has been granted a new cultivation license by Health Canada. Production is expected to begin in early 2025, marking ...

Inventive deal structures are on the rise within China’s life sciences industry, with the “NewCo” model having garnered significant interest ...

Mubadala Investment Company has empowered its new specialty pharmaceutical business, KELIX Bio, to acquire a 100 per cent ...

The draft amendment to the Law on Pharmacy plays a crucial role in promoting innovation and modernisation of the Vietnamese ...